Aptorum Group Limited (NASDAQ:APM) Short Interest Down 25.0% in March

Aptorum Group Limited (NASDAQ:APM) was the target of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 43,900 shares, a drop of 25.0% from the February 28th total of 58,500 shares. Based on an average daily trading volume, of 2,240,000 shares, the short-interest ratio is currently 0.0 days. Approximately 1.0% of the shares of the company are short sold.

Aptorum Group Price Performance

Shares of Aptorum Group stock opened at $0.84 on Tuesday. The company’s fifty day moving average price is $1.07 and its two-hundred day moving average price is $1.27. Aptorum Group has a 52-week low of $0.46 and a 52-week high of $11.19.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.